Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
5 DIRECTOR EXERCISE OPTIONS ON MAY-10TH -NOT!!
They've received stock options! Nothing more, nothing less!
Please read sec-filing.
( This Option will vest and become exercisable one year from the date of grant, but only if Participant has attended at least 75% of all meetings of the Board of Directors held during the Company's preceding fiscal year while Participant was a Director of the Company. If Participant does not attend at least 75% of all such meetings then this option will not vest and shall terminate.)
http://yahoo.brand.edgar-online.com/fetchFilingFrameset.aspx?FilingID=4417030&Type=HTML
CF
This is what he wrote 2 years ago; he knwos what INSM & IPLEX is about! Also mentioning off label usage!
Insmed Incorporated
Ticker: INSM
Description: Insmed develops medicines for the treatment of metabolic diseases and endocrine disorders. Insmed’s most advanced drug, a proprietary complex of rhIGF-I, is currently in Phase III for GHIS, a severe growth disorder. Insmed expects to file for marketing approval for GHIS in 2004. Insmed’s anti-cancer medicine, rhIGFBP-3, is expected to enter clinical trials in 2004.
Website: http://www.insmed.com
The information below is based on the most recent information we have received from analysts and the companies participating in The REIT Report. We encourage you to visit the company's web site for updates. “On November 17, 2003, we initiated coverage of INSM shares with a Market Outperform rating and 12-month price target of $8 (30x our 2007 EPS estimate of $0.68 discounted annually at 35%). Insmed Incorporated (Nasdaq: INSM) is a biopharmaceutical company developing recombinant human insulin-like growth factor-I (rhIGF-I) in combination with recombinant human IGF-I binding protein –3 (rhIGFBP-3) for the treatment of various endocrine disorders. The equimolar complex of rhIGF-I and rhIGFBP-3 is designated as rhIGF-I/rhIGFBP-3 or SomatoKine and is in a Phase III pivotal trial in children with growth hormone insensitive syndrome (GHIS). SomatoKine is also in Phase II trials for severe burn injury, hip fracture in osteoporotic patients, and severe insulin resistant Type 1 and Type 2 diabetes mellitus. Pharmacia’s free IGF-I went through all phases of clinical development and was shown to be efficacious for the treatment of growth retardation in children with GHIS. The drug was approved in Europe. However, Pharmacia never marketed the product. No other IGF-I drug is currently approved and marketed and GHIS remains an unmet medical need. We believe INSM’s pivotal Phase III trial of SomatoKine in children with GHIS has a high probability of success because (a) free IGF-1 is effective and (b)apharmacokinetic study has established that once daily subcutaneous administration of SomatoKine is equally effective as a twice-daily subcutaneous injection free IGF-I in elevating serum IGF-I level in patients which in turn restores IGF-I functions in vivo. We expect SomatoKine to be approved and launched in 2005 and project sales of $7.8 million in 2005, $44.7 million in 2006 and $140.4 million in 2007. Physicians thought leaders find SomatoKine to be promising and once approved, to find significant off-label use in the general GHIS population, in late-stage diabetic patients with severe insulin resistance, in patients with severe burn injury, and in osteoporotic patients suffering from hip facture. INSM's pipeline also consists of rhIGFBP-3 in early clinical development as an anti-cancer therapeutic agent for a variety of tumor types. We consider INSM shares, at a technology value of around $80 million, to be significantly undervalued compared to its peers. We reiterate our Outperform rating for INSM shares. Our 12-month target price remains unchanged at $8.00.” (February 11, 2004)
-NAVDEEP S. JAIKARIA, RODMAN & RENSHAW
http://www.thereitreport.com/pub/co/526
CF
According to Mr. P. Young in yesterday's CC, they will have a presentation @ PENS! Personally, I do expect a PR about this and R&R's conference by tomoorow!
Would be a great move, if that would coincide with 2 new analyst reports of CEUT & Lazard!
When there is more insight in TRCA's sales afforts & revenue (and there is probably after tonight's CC), both analysts will have a much better view on market penetration this year!
In the meanwhile...
CF
Thanks again Jelly; Do you have idea why Briefing is not in agenda?
Could this be indeed for TRCA's tanking? Withdrawal of briefing, hearing, trial?
CF
=================================================================
Is this the reason for TRCA's tanking?
by: sipher_l (40/Manhattan Beach, CA)
Long-Term Sentiment: Strong Buy 05/02/06 04:22 pm
Msg: 91404 of 91420
Saundra B. Armstrong
http://www.cand.uscourts.gov/CAND/Calendar.nsf/572d47d88520f842882566a2007f2b59/ 761fa1e4a8b2aeb688256c0700589c0d?OpenDocument
Magistrate Judge Edward M. Chen
http://www.cand.uscourts.gov/CAND/Calendar.nsf/572d47d88520f842882566a2007f2b59/ f01763d18a9639de88256a3a00567b0d?OpenDocument
Judge Claudia Wilken
http://www.cand.uscourts.gov/CAND/Calendar.nsf/572d47d88520f842882566a2007f2b59/ 1dccb80c9d1ab870882566a30060ea74?OpenDocument
Is there any reason...
why the Briefing is NOT scheduled in one of the Judges' Calendar?
Friday 05/05/2006
09:00 AM NO CALENDAR
-----------------------------------------------
...Could it be that, because of previous denial on 26th/4 to move trial to september, that DNA is withdrawing the case (briefing / hearing / trial) & consequently TRCA as well (have to)?
Anyone, any idea? Abharploonta maybe? Please advice. Thanks. Appreciated a lot
L.S.
Thanks Jelly for immediate reply! The other question,
Is there any reason...
why the Briefing is NOT scheduled in Judge's Armstrong her Calendar?
Friday 05/05/2006
09:00 AM NO CALENDAR
-----------
http://tinyurl.com/o65wl
Does anyone has a clue? Or is Judge Armstrong NOT presiding?
CF
Is there any reason...
why the Briefing is NOT scheduled in Judge's Armstrong her Calendar?
Friday 05/05/2006
09:00 AM NO CALENDAR
-----------
http://tinyurl.com/o65wl
& Jelly do you have a link or cut/paste part where it's stated that The Court Denied Tercica's Request?
CF
Tercica's booth is near the stairs to the dungeon!
Floorplan (http://www.onlinefloorplan.com/pediatric06/1.htm ): Booth 539 (Insmed'd booth ) 4times as big as Abbott's booth and is surrounded by:
Booth 634: Pediatrix Medical Group
Booth 535: Columbus Children Hospital
Booth 536: MUSC Children's Hospital
Booth 637: Abbott.
http://www.onlinefloorplan.com/pediatric06/businesscard.asp?CompanyName=Insmed%2 0Incorporated&showname=Pediatric%20Academic%20Societies%202006
...That's the difference...INSM is surrounded by 'Childrens', where as TRCA is muffled away near the dungeon and surrounded by mufty-flufty organozations / companies!
Sure, it's very tempting to be the investor fly-on-the-wall, to notice the difference in traffic & to enjoy Mr.P.Young's sales pitch over & over again! Hmmmm....
CF
...Important! & sofar not noted, Insmed will also present at ENDO 2006.
Stonefly As well during Endo2006 !!
by: l_oompa (40/,)
Long-Term Sentiment: Strong Buy 04/25/06 07:15 am
Msg: 89167 of 89343
Stonefly Group is not only responsible for the marketing efforts of IPLEX during the PAS-meeting; this agency is also representing INSM during the ENDO 2006!!!
http://www.endo-exhibitplanner.org/endo2006/ec/forms/attendee/index.aspx?content =vbooth&id=82
http://www.endo-society.org/endo06/
6/24-6/27 At the Endo2006 Conference, INSM will be represented by Stonefly again!!
Take a look at the floorplan and convince yourself that INSM could not have gotten a better place!!
...On the MAIN CORRIDOR, on the way to the restaurant=> MAXIMUM EXPOSURE during ENDO 2006 will be the consequence!!
WWnOL
CF
Do I understand correctly, that ONLY the CMC is rescheduled to 6/14/2006 and that this ridiculous Hearing is terminated; that the hearing is NOT rescheduled!
Pls advice. Thanks.
Cheers, CF
Case dimissed? Hearing & CMC cancelled!!
http://www.cand.uscourts.gov/CAND/Calendar.nsf/572d47d88520f842882566a2007f2b59/ 761fa1e4a8b2aeb688256c0700589c0d?OpenDocument
Anyone any news?? Case dismissed? Hearing as well as CMC no longer on roll / schedule anymore for tommorow!
...Highly speculative, but could it be that...INSM indeed Knocked Out TRCA?
Abharploonta, do you have as insider, any opinion about this?
Cheers, CF
Ventiv Health involved in organizing PAS-Meetings presentation! Take also a close look at our neighbours at the conference. The right drug at the right place.
It's tempting to believe that based upon involvement of Ventive Health, the perfect location, the size of the booth (4 times Abbott's) and the perfect audience INSMED is indeed planning on launching IPLEx at PAS-meeting!
Would be great!
=================================================================
Re:Ventiv Health, Commercial Partner
by: skip1cf (40/Beverly Hills, CA)
Long-Term Sentiment: Strong Buy 04/14/06 12:59 pm
Msg: 86647 of 86662
Do your DD and you'll end up with same conclusions. Allow me to sum up the relationship in links.
INSM will attend / present PAS-meeting
* http://www.pas-meeting.org/2006SanFran/Exhibits/ExhListing.htm#I
* Booth 539 is INSMED's ( http://www.onlinefloorplan.com/pediatric06/1.htm )
* Double click on Booth 539 and you'll get this information:
Insmed Incorporated
Booth: 539
Claire Koczak
c/o Stonefly Communications Group
Glen Allen VA 43082-0000 USA
614/543-6509 PH
614/540-3155 FX
ckoczak@stoneyflygroup.com
http://www.stoneflygroup.com/
(An inVentiv Health Company)
http://www.inventivhealth.com/home.asp
...It's simple math! In this case a hidden one, cos INSM is NOT intending to confirm anything before 18th hearing. That's why I / we should do our own research!
...I understand your cynism, however how expensive do you want your cynism to be? - Will be pretty expensive, if you wait too long.
Long Scf
Posted as a reply to: Msg 86635 by parentsnongratae
CMC & Hearing are scheduled on 18th!!
-----------
01:00 PM C-05-05027E TERCICA, INC. VS. INSMED INCORPORATED
DEFENDANT'S MOTION TO DISMISS THE FIRST AMENDED COMPLAINT AND TO STRIKE PORTIONS OF THE FIRST AMENDED COMPLAINT
CASE MANAGEMENT CONFERENCE
http://www.cand.uscourts.gov/CAND/Calendar.nsf/572d47d88520f842882566a2007f2b59/761fa1e4a8b2aeb68825...
Cheers, C.
Trading halted?...Anyone know why?
CF
Will there be any announcement that ATNEA indeed did the review? And if so, where will this confirmation be published?
Please advice, Thanks.
CF
No NEWS; NON Event!!
"We believe we are in exactly the right field at the right time with the opening of our Stem Cell MicroBank(TM) and we anticipate announcing further developments, and additional clients, in future months," Mr. Fulkerson said.
Scandalous!! Management pumping own shares!! No facts!! only pumping on sentiments!! Be aware!
Cheers, CF.
...And I hope that you rely on facts! In tomorrow's News paper...
http://theseoultimes.com/ST/?url=/ST/db/read.php?idx=3016
(...)Schatten said. "The ethical and legal implications are important, but the most important thing for us is just to have discoveries that are independently confirmed and extended."
Within weeks, Schatten, a vocal champion of embryonic stem cell and cloning research, broke with Hwang over ethical concerns. (...)
...It makes 1 think...Is there more to come?
Ch. CF
<<Based on the number of new Med Spa's who may be fronting for them, it looks like projected earnings could be quite large. No idea really what that number could be, looks like a good play to us.>>
...May / Could / Could...Like the dreaming sofar?
...Wake up guys! L'histoire repete! The numbers will cause CLBE to go back to it's origins, which is the $0.02-$0.03 range. Wishfull thinking will not pump this 1.
...Facts will support above mentioned range! (anyone any idea what happened wit the patent approval process for Life Stem's medical device?- It's too long, Too quite!!)
Cheers, CF
...You may be right CW, may be...but you've to admit that the $0.02-$0.03 range is coming near! Dangerously near!
...Hope you're wrong, although you know my stance!
Cheers, CF
...Please continue cumulating! You must have the time of your life! Remind, that if you do stop to buy, stock will go back to original position of $0.02.
...So on behalf of lots of investors (who bougt in the $0.02-$0.03 range) please continue!
Cheers, CF.
<<...I do hope for all involved that CLBE management will come with a PR, so we all feel a bit more assured.
My advice to you CW, enjoy your increase...and do not forget to take profits, once in a while!>>
...And? Did you? Did you take your profits?...To me it's clear that this stock is pumped to these levels by management, and that we (investors) are paying the price!
...Ofcourse we do (and we are willing to) 'cos expectations are initiated! There's only 1 thing missing and that is a well wriiten PR, why this is happening.
...Even the old saying 'Buy on the rumour, sell on the news' is not appropriate, 'cos there is even no rumour!!
...Pls, all, be aware of that, take your profit and watch this stock form the sideline! As long as there's NO news, this stock should go back to it's low $0.02.
Cheers, CF.
PS. Still anxious to know whether you were able to profit in on time CW?
Hi Coinstarz, Is there any reason why there is not a agenda on the site? An agenda, where all Conferences, Investor meetings,...are listed.
Maybe, I'm overlooking this, but I can not find one...Or you may have a good rason why there is not such an item.
Please advice,
Thanks, CF.
<<You're probably a street sweeper>>...Maybe CW, maybe. If, then for sure a wealthy one....I was able to accumulate this stock when it was in it's high $0.01 and low $0.02!
...My concern is, and will be as long as I have not seen any PR from CLBE, this sudden increase in price! Nothing justifies this sudden increase. If there is NO rationale for this increase, it will as easily decrease!...and go back to...where it stayed for over 4 months...the $0.02 range.
...I do hope for all involved that CLBE management will come with a PR, so we all feel a bit more assured.
My advice to you CW, enjoy your increase...and do not forget to take profits, once in a while!
Cheers, CF
PS Thanks for all your valuable input; I highly respect you!
...One will not hear that I'm not happy with this close, but...what is going on? Someone any idea? It keeps on & on! Any rationale?
Cheers, CF.
<<There was known that will retrace from .10 before next push>>
Can not find that info, but I appreciate the Web Adress you gave. Indeed, on there is the same mistake made. I agree, thata lot of valuable information is to find on that site. However, a lot of information is outdated.
...One of them I pointed out in earlier post. And no, it's not my purpose to discredit this stock. What I'm trying to find is a BB, where no BS is written, and where info is credible and well-valued.
...An example of such a BB on I-hub is for instance, DNAG. I'm trying to find an answer, why the price of CLBE went up, without any reason. Was hoping that longs on here could provide an answer. (Also on Nanalyze, no one has an answer).
...That's why I wrote my 'theory' in my first post on I-hub_CLBE. Nobody has a clue sofar, so I expect that a logical pull back can be expected now and the upcomng days. If you have a different opinion and wants to elaborate on it, please do so.
Cheers, CF
CW, That is indeed an impressive list! Unfortunately, None of them are aptents which are owned by CLBE. Try, for yourself.
..For instance the second patent
nventors: Herbots; Ivan Maurice Alfons Jan (Wetteren, BE); Busch; Alfred (Londerzeel, BE)
Assignee: The Procter & Gamble Company (Cincinnati, OH)
Appl. No.: 462613
Filed: January 10, 2000
PCT Filed: July 9, 1997
PCT NO: PCT/US97/12445
PCT PUB.NO.: WO99/02640
PCT PUB. Date: January 21, 1999
Current U.S. Class: 510/392; 510/300; 510/306; 510/321; 510/374
Intern'l Class: C11D 003/00; C11D 009/00; C11D 007/42
Field of Search: 510/392,320,306,300,321,374
....As you can see, this one is owned by P&G!! And this is not the only one. I appreciate you effort...you may have provided a wrong list.
If this is the case, I'm still anxiuos, to review your other list with 170 patents. Thanks.
Cheers, CF.
Short on a OTC-stock?? Can you provide the link where they reported, that CLBE would quit with AGOARCOM? TIA.
...In the meanwhile, keep close eye on latest developments! I do expect that CLBE management will stop pumping this stock, now exposure has stopped, as of today, on AGORACOM.
...Can you also provide a link, where all the 170 patents are listed. I follow developments on CLBE closely and was not aware that they had SO many, Thanks!
Cheers, CF.
CW, I would not call myself nuts...more realistic. CLBE went up on no news, just after announcement made by AGORACOM. This was the only 'formal' communication / attention channel for CLBE (despite initiatives like Ihub).
...It's all to coincidental. Unless, they will report some serious news, I expect price to go back to low $0.02's.
...I'll keep a close eye on developments, today and upcoming days, and will see if the slowdown of yesterday, will reverse into a pullback.
Cheers, CF
PS. Why is it, in your opinion, that they dropped AGORACOM? - Which is not true in the first place, while AGORACOM did quit the relationship. Anyway, still anxious to hear your opinion.
...Agoracom finally took CLBE from their BB. I suspect that as of tomorrow, the price will drop, back to the low $0.02.. There's no need, for CLBE management anymore, to build the prices, as they did the last 1.5 week.
...Agoracom made their decision; CLBE did try to pump in such way to keep this BB. Unforntunately!
Now they have to start again and to start to make themselve credible again.
Curious, what will happen tomorrow.
Cheers, CF.
It's clear that there is no real news! So what's happening right now? Volume is 7-8times daily volume!
I suspect that Management has decided to buy up a lot of shares themselves, at least to get the price to a level of $0.2. Helped buy 'naieve' investors, price is going now in 2 days from $0.025 - $0.081=> over 200%.
I guess that management is hoping that a lot of 'naieve' investors are starting to buy this stock again, especially now that it is still exposed on AGORACOM.com.
AGORACOM.com has informed investors that they will be quitting the service, due to....(AGORACOM.com gets paid $0.2/share; but at this point in time nobody is willing to pay that)
And if AGORACOM.com is paid this way, then there are so many other creditors who get paid in the same way.
So bottomline is, that I suspect that CLBE Management is buying up shares, with the intention to raise the price (helped by naive investors who are afraid to miss the boat) in order to enable creditors to cash at $0.2/share!!
Be aware, and don't be suprised that the market gets floated with millions of new shares in upcoming days!!
Much of Fortune, CF.